Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.
Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, an...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/9f792cf72dd44722b6c2f5ed8b38fc7e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:9f792cf72dd44722b6c2f5ed8b38fc7e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:9f792cf72dd44722b6c2f5ed8b38fc7e2021-11-18T06:05:49ZStrongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.1553-73661553-737410.1371/journal.ppat.1003263https://doaj.org/article/9f792cf72dd44722b6c2f5ed8b38fc7e2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23592987/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, and Infective Dermatitis associated with HTLV-1 (IDH), appear to be risk factors for the development of HTLV-1 related diseases. We used high-throughput sequencing to map and quantify the insertion sites of the provirus in order to monitor the clonality of the HTLV-1-infected T-cell population (i.e. the number of distinct clones and abundance of each clone). A newly developed biodiversity estimator called "DivE" was used to estimate the total number of clones in the blood. We found that the major determinant of proviral load in all subjects without leukemia/lymphoma was the total number of HTLV-1-infected clones. Nevertheless, the significantly higher proviral load in patients with strongyloidiasis or IDH was due to an increase in the mean clone abundance, not to an increase in the number of infected clones. These patients appear to be less capable of restricting clone abundance than those with HTLV-1 alone. In patients co-infected with Strongyloides there was an increased degree of oligoclonal expansion and a higher rate of turnover (i.e. appearance and disappearance) of HTLV-1-infected clones. In Strongyloides co-infected patients and those with IDH, proliferation of the most abundant HTLV-1⁺ T-cell clones is independent of the genomic environment of the provirus, in sharp contrast to patients with HTLV-1 infection alone. This implies that new selection forces are driving oligoclonal proliferation in Strongyloides co-infection and IDH. We conclude that strongyloidiasis and IDH increase the risk of development of HTLV-1-associated diseases by increasing the rate of infection of new clones and the abundance of existing HTLV-1⁺ clones.Nicolas A GilletLucy CookDaniel J LaydonCarol HlelaKristien VerdonckCarolina AlvarezEduardo GotuzzoDaniel ClarkLourdes FarréAchiléa BittencourtBecca AsquithGraham P TaylorCharles R M BanghamPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 9, Iss 4, p e1003263 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
| spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Nicolas A Gillet Lucy Cook Daniel J Laydon Carol Hlela Kristien Verdonck Carolina Alvarez Eduardo Gotuzzo Daniel Clark Lourdes Farré Achiléa Bittencourt Becca Asquith Graham P Taylor Charles R M Bangham Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. |
| description |
Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, and Infective Dermatitis associated with HTLV-1 (IDH), appear to be risk factors for the development of HTLV-1 related diseases. We used high-throughput sequencing to map and quantify the insertion sites of the provirus in order to monitor the clonality of the HTLV-1-infected T-cell population (i.e. the number of distinct clones and abundance of each clone). A newly developed biodiversity estimator called "DivE" was used to estimate the total number of clones in the blood. We found that the major determinant of proviral load in all subjects without leukemia/lymphoma was the total number of HTLV-1-infected clones. Nevertheless, the significantly higher proviral load in patients with strongyloidiasis or IDH was due to an increase in the mean clone abundance, not to an increase in the number of infected clones. These patients appear to be less capable of restricting clone abundance than those with HTLV-1 alone. In patients co-infected with Strongyloides there was an increased degree of oligoclonal expansion and a higher rate of turnover (i.e. appearance and disappearance) of HTLV-1-infected clones. In Strongyloides co-infected patients and those with IDH, proliferation of the most abundant HTLV-1⁺ T-cell clones is independent of the genomic environment of the provirus, in sharp contrast to patients with HTLV-1 infection alone. This implies that new selection forces are driving oligoclonal proliferation in Strongyloides co-infection and IDH. We conclude that strongyloidiasis and IDH increase the risk of development of HTLV-1-associated diseases by increasing the rate of infection of new clones and the abundance of existing HTLV-1⁺ clones. |
| format |
article |
| author |
Nicolas A Gillet Lucy Cook Daniel J Laydon Carol Hlela Kristien Verdonck Carolina Alvarez Eduardo Gotuzzo Daniel Clark Lourdes Farré Achiléa Bittencourt Becca Asquith Graham P Taylor Charles R M Bangham |
| author_facet |
Nicolas A Gillet Lucy Cook Daniel J Laydon Carol Hlela Kristien Verdonck Carolina Alvarez Eduardo Gotuzzo Daniel Clark Lourdes Farré Achiléa Bittencourt Becca Asquith Graham P Taylor Charles R M Bangham |
| author_sort |
Nicolas A Gillet |
| title |
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. |
| title_short |
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. |
| title_full |
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. |
| title_fullStr |
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. |
| title_full_unstemmed |
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. |
| title_sort |
strongyloidiasis and infective dermatitis alter human t lymphotropic virus-1 clonality in vivo. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/9f792cf72dd44722b6c2f5ed8b38fc7e |
| work_keys_str_mv |
AT nicolasagillet strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT lucycook strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT danieljlaydon strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT carolhlela strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT kristienverdonck strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT carolinaalvarez strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT eduardogotuzzo strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT danielclark strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT lourdesfarre strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT achileabittencourt strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT beccaasquith strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT grahamptaylor strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo AT charlesrmbangham strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo |
| _version_ |
1718424621803372544 |